க்ளீன் லெவின் நோய்க்குறி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from க்ளீன் லெவின் நோய்க்குறி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In க்ளீன் லெவின் நோய்க்குறி Today - Breaking & Trending Today

42-Year-Old Man Sleeps For 300 Days A Year; Family Feeds And Bathes Him While Asleep

42-Year-Old Man Sleeps For 300 Days A Year; Family Feeds And Bathes Him While Asleep
ibtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ibtimes.com Daily Mail and Mail on Sunday newspapers.

Kanvari Devi , Lichmi Devi , Beth Goodier , Sharik Tovar , Axis Hypersomnia , Kleine Levin Syndrome , Levin Syndrome , பெத் நல்லது , ஷரிக் தோவர் , க்ளீன் லெவின் நோய்க்குறி , லெவின் நோய்க்குறி ,

KLS Foundation Launches First-Ever Kleine Levin Syndrome Patient Registry

KLS Foundation Launches First-Ever Kleine Levin Syndrome Patient Registry
Share Article
SAN JOSE, Calif. (PRWEB)
January 25, 2021
The Kleine-Levin Syndrome (KLS) Foundation today launched a first-of-its-kind patient registry. The registry will collect and organize information about KLS patients around the world and inform the medical and scientific research communities about KLS symptoms, episode triggers, medications and more – in a way never done before.
Kleine-Levin Syndrome is a rare neurological disorder characterized by recurring periods of excessive amounts of sleep, altered behavior and a reduced understanding of the world. Each episode lasts days, weeks or months during which time all normal daily activities stop. In between episodes, those with KLS appear to be in perfect health with no evidence of behavioral or physical dysfunction. However, individuals function daily with the frig ....

Jeff Broderick , Stephen Maier , Foundation Steve Maier , Beneufit Inc , Health Insurance Portability , Kleine Levin Syndrome , Levin Syndrome , Accountability Act , European General Data Protection Regulation , Review Board , Orphan Studies , Press Release , ஜெஃப் ப்ரொடெரிக் , ஸ்டீபன் மேயையர் , அடித்தளம் ஸ்டீவ் மேயையர் , க்ளீன் லெவின் நோய்க்குறி , லெவின் நோய்க்குறி , பொறுப்பு நாடகம் , ஐரோப்பிய ஜநரல் தகவல்கள் ப்ரொடெக்ஶந் ஒழுங்குமுறை , விமர்சனம் பலகை , ஆர்ஃபந் ஆய்வுகள் , ப்ரெஸ் வெளியீடு ,

NLS Pharmaceutics Ltd. Announces Notice of Allowance of a New Technology Patent Covering Attention Deficit Hyperactivity Disorder & Narcolepsy

Press release content from PR Newswire. The AP news staff was not involved in its creation.
NLS Pharmaceutics Ltd. Announces Notice of Allowance of a New Technology Patent Covering Attention Deficit Hyperactivity Disorder & Narcolepsy
January 21, 2021 GMT
STANS, Switzerland, Jan. 21, 2021 /PRNewswire/ NLS Pharmaceutics Ltd. (NLS), a Swiss biotech firm focusing on the development of novel treatments of rare neurological diseases including narcolepsy, idiopathic hypersomnia and Kleine-Levin Syndrome and of neurodevelopmental disorders, such as Attention Deficit Hyperactivity Disorder (ADHD), announced today that the European Patent Office (EPO) issued a Notice of Intention to Grant NLS’s patent application covering a novel formulation of mazindol for treatment of ADHD and sleep related disorders. On November 23, 2020, the Canadian Intellectual Property Office (CIPO) issued a similar notice of allowance for the counterpart Canadian application. NLS awaits the impendin ....

Alex Zwyer , European Patent Office , Canadian Intellectual Property Office , Pharmaceutics Ltd , Kleine Levin Syndrome , Attention Deficit Hyperactivity Disorder , Orphan Drug Designation , Technology Issues , Products And Services , Western Europe , Product Testing , Intellectual Property , Technology Law And Ethics , Pharmaceutical Manufacturing , Health Care Industry , Pr Newswire , Attention Deficit Disorders , Neurological Disorders , Medical Research , Medical Biotechnology Industry , Child And Teen Health , Clinical Trials , Corporate News , Sleep Disorders , Diseases And Conditions , ஐரோப்பிய காப்புரிமை அலுவலகம் ,